Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.
about
Barrett's esophagus in 2016: From pathophysiology to treatmentEosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic InfectionsDistinguishing GERD from eosinophilic oesophagitis: concepts and controversiesWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesProton pump inhibitors for eosinophilic oesophagitisManagement of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approachesProton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differencesLack of compliance with consensus recommendations on the diagnosis of eosinophilic esophagitis (EoE) in published prevalence studies. A clinical and systematic review.Epidemiology of eosinophilic esophagitis.Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophiliaCan chronic gastritis cause an increase in fecal calprotectin concentrations?Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisA possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in ratsThe aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasisOmeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cellsPractice patterns for the evaluation and treatment of eosinophilic oesophagitis.Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice.Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisTryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux diseaseAcid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus(Gut 2014;63:1229-1237).Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosisAssociation of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009Inhibition of gastric perception of mild distention by omeprazole in volunteersClinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean PatientsProton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.Effect of proton pump inhibitor on esophageal eosinophilia.Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.Acid burn or cytokine sizzle in the pathogenesis of heartburn?Bacterial infections in end-stage liver disease: current challenges and future directionsIdiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Probe for the measurement of cell surface pH in vivo and ex vivo.Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance.Novel pH-Sensitive Cyclic PeptidesType of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty.Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients.Proton pump inhibitors and gastroenteritis.
P2860
Q26751171-DD903815-4CCB-4667-B1EC-3A3932004225Q26799615-BD295395-53C2-4646-8C24-CA4846518CE2Q26860824-AEB0E560-6F5E-4C3A-9715-93BAA786BB1CQ26991991-8C954F3E-AA85-4CFF-B5A7-DFC06C9DD0DAQ27008939-5F1FF15D-2A9E-4925-BF33-8F9401F5459EQ28080583-5274FF23-EB58-4CBF-B391-7AC331CEC5ECQ28082447-8DA93610-C88E-470C-8972-65E5E973CEA3Q30248292-5CFF23BF-1DC2-4F55-9C22-30D83B31A623Q33606276-6258F470-C715-42E0-9955-9A5315F8A08CQ33838272-7A70CD66-D7D1-4ABF-98F6-EF48FB506C58Q33998635-DE8385D5-9208-412A-8380-C78C2D82B051Q34296297-F0AF3EBC-1F80-4DA0-AAB0-F1E5B810BCC4Q34352867-7E80EA35-B4D5-4DB5-BE4F-8E1A330354E0Q34445624-4FEFFA1E-552C-4832-BD5B-016867C5560CQ34485137-D66009ED-5867-4B31-A68A-3B850F0E4B40Q34490922-DA5C9A7E-1028-4AB5-A1D5-F2CECCA5D7EBQ34996201-4EC9DFE9-23AE-4A36-BFC2-780AB2D3274EQ34997762-1DF55A10-E937-497C-8B45-1069B5FAD8BCQ35079589-EC5D8C1B-14F5-454B-A6B7-783129D4C09EQ35213444-E182BF23-9E0A-4898-8582-766B4DCC0686Q35430468-36C3A44F-41B7-4D64-8CBA-8377EBB20851Q35908085-E8AD78E9-C18B-4BA8-8165-71E8A330404CQ36019858-98D8C26B-31F1-40D8-BC65-AC150AA91FC2Q36215509-7B1E20F3-6EC9-4902-B638-BEE002B77F19Q36351909-5F5E1AE3-AC31-4518-8E7C-C89381879AC5Q36412868-D7274D81-184F-463D-B921-FF3FA6748B9FQ36472730-F9F22218-E7DF-41E3-BB66-65C42C7EAB74Q36553408-E25BF24F-3E78-4B11-AE40-14BE59D87C5CQ36554740-1F4F8E35-D28F-4B7D-8182-F5AEAD7DD34CQ36578734-D3556EF1-6440-4033-93C5-563EA1492639Q36660783-AD8C0F08-4453-4D4F-9298-254D5FA47A31Q36705999-BC0B73D8-5968-49BF-9222-1FBE335B5EF9Q37013159-7B66C65D-3456-46C5-B854-BCAA70B7FEF0Q37126735-A079F3EA-1409-477D-AE15-04DF6A6D6E2FQ37151525-D99FAE70-B2B8-4B3B-B387-C35CA5694982Q37169018-22DC9D0C-7E27-4A8C-9BA2-736216C9EE06Q37184627-F6867D62-91F1-43EE-890D-146E6105ADB5Q37230596-8F036A4E-EBDF-4946-AE04-3C15ED7D082BQ37268285-A4A5360E-72DE-4F65-B1DB-7C3736B9B5E2Q37341862-A4B35446-546B-41D9-AE49-1DD246AB6A77
P2860
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Potential anti-inflammatory ef ...... of the clinical implications.
@ast
Potential anti-inflammatory ef ...... of the clinical implications.
@en
Potential anti-inflammatory ef ...... of the clinical implications.
@nl
type
label
Potential anti-inflammatory ef ...... of the clinical implications.
@ast
Potential anti-inflammatory ef ...... of the clinical implications.
@en
Potential anti-inflammatory ef ...... of the clinical implications.
@nl
prefLabel
Potential anti-inflammatory ef ...... of the clinical implications.
@ast
Potential anti-inflammatory ef ...... of the clinical implications.
@en
Potential anti-inflammatory ef ...... of the clinical implications.
@nl
P2093
P2860
P1476
Potential anti-inflammatory ef ...... of the clinical implications.
@en
P2093
Ramalinga R Kedika
Rhonda F Souza
Stuart Jon Spechler
P2860
P2888
P304
P356
10.1007/S10620-009-0951-9
P577
2009-11-01T00:00:00Z
P5875
P6179
1044721433